NO306700B1 - Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister - Google Patents

Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Info

Publication number
NO306700B1
NO306700B1 NO944214A NO944214A NO306700B1 NO 306700 B1 NO306700 B1 NO 306700B1 NO 944214 A NO944214 A NO 944214A NO 944214 A NO944214 A NO 944214A NO 306700 B1 NO306700 B1 NO 306700B1
Authority
NO
Norway
Prior art keywords
pct
rectal administration
alkylsulfonamides
agonists
pharmaceuticals
Prior art date
Application number
NO944214A
Other languages
English (en)
Norwegian (no)
Other versions
NO944214D0 (no
NO944214L (no
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of NO944214D0 publication Critical patent/NO944214D0/no
Publication of NO944214L publication Critical patent/NO944214L/no
Publication of NO306700B1 publication Critical patent/NO306700B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO944214A 1992-05-07 1994-11-04 Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister NO306700B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (3)

Publication Number Publication Date
NO944214D0 NO944214D0 (no) 1994-11-04
NO944214L NO944214L (no) 1994-11-07
NO306700B1 true NO306700B1 (no) 1999-12-13

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944214A NO306700B1 (no) 1992-05-07 1994-11-04 Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Country Status (33)

Country Link
US (1) US5705506A (ko)
EP (1) EP0639072B1 (ko)
JP (1) JPH07506570A (ko)
KR (1) KR100253111B1 (ko)
AT (1) ATE163850T1 (ko)
AU (1) AU670083B2 (ko)
BE (1) BE1007024A5 (ko)
BG (1) BG62120B1 (ko)
BR (1) BR1100108A (ko)
CA (1) CA2135179C (ko)
CH (1) CH685920A5 (ko)
CY (1) CY2039B1 (ko)
CZ (1) CZ283512B6 (ko)
DE (1) DE69317418T2 (ko)
ES (1) ES2113533T3 (ko)
FR (1) FR2690847B1 (ko)
GB (2) GB9209882D0 (ko)
GR (1) GR3026584T3 (ko)
HK (1) HK95697A (ko)
HU (2) HU227338B1 (ko)
IE (1) IE75203B1 (ko)
IL (1) IL105468A (ko)
IT (1) IT1261471B (ko)
NO (1) NO306700B1 (ko)
NZ (1) NZ252132A (ko)
OA (1) OA10109A (ko)
RO (1) RO112993B1 (ko)
RU (1) RU2118527C1 (ko)
SG (1) SG46649A1 (ko)
TW (1) TW231970B (ko)
UA (1) UA37206C2 (ko)
WO (1) WO1993021916A1 (ko)
ZA (1) ZA933178B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
KR100505464B1 (ko) * 1998-03-26 2005-08-04 후지사와 야꾸힝 고교 가부시키가이샤 서방성 제제
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
PL2124556T3 (pl) 2006-10-09 2015-02-27 Charleston Laboratories Inc Kompozycje farmaceutyczne
CA3066426A1 (en) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
EP2451274B1 (en) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmaceutical compositions
CN105193809B (zh) 2010-10-15 2019-07-16 康特拉医药公司 用于治疗运动障碍的血清素受体激动剂组合物
PL2838517T3 (pl) 2012-04-18 2018-03-30 Contera Pharma Aps Przeznaczony do podawania doustnego preparat farmaceutyczny na potrzeby udoskonalonego leczenia zaburzeń ruchowych
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
WO2018011181A1 (en) 2016-07-11 2018-01-18 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
NZ197998A (en) * 1980-08-12 1985-08-16 Glaxo Group Ltd 5-amino(methyl)-1h-indol-3-ylalkaneamines
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
BE903778A (fr) * 1984-12-04 1986-06-03 Glaxo Group Ltd Derives d'indoles.
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
ATE92057T1 (de) * 1987-08-13 1993-08-15 Glaxo Group Ltd Indol-derivate.
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
GB2266665A (en) 1993-11-10
NO944214D0 (no) 1994-11-04
ES2113533T3 (es) 1998-05-01
ATE163850T1 (de) 1998-03-15
BE1007024A5 (fr) 1995-02-21
BR1100108A (pt) 1999-12-07
SG46649A1 (en) 1998-02-20
ZA933178B (en) 1994-01-10
IT1261471B (it) 1996-05-23
FR2690847A1 (fr) 1993-11-12
WO1993021916A1 (en) 1993-11-11
IL105468A0 (en) 1993-08-18
HK95697A (en) 1997-08-08
HUT71418A (en) 1995-11-28
CY2039B1 (en) 1998-04-30
EP0639072B1 (en) 1998-03-11
CZ272394A3 (en) 1995-10-18
RU2118527C1 (ru) 1998-09-10
GB9209882D0 (en) 1992-06-24
DE69317418D1 (de) 1998-04-16
GB9309209D0 (en) 1993-06-16
UA37206C2 (uk) 2001-05-15
CH685920A5 (fr) 1995-11-15
US5705506A (en) 1998-01-06
GR3026584T3 (en) 1998-07-31
CA2135179C (en) 2000-12-05
CA2135179A1 (en) 1993-11-11
BG62120B1 (bg) 1999-03-31
TW231970B (ko) 1994-10-11
DE69317418T2 (de) 1998-07-30
NO944214L (no) 1994-11-07
IE75203B1 (en) 1997-08-27
BG99167A (bg) 1995-06-30
EP0639072A1 (en) 1995-02-22
RO112993B1 (ro) 1998-03-30
GB2266665B (en) 1996-05-22
CZ283512B6 (cs) 1998-04-15
ITRM930286A1 (it) 1994-11-06
IE930339A1 (en) 1993-11-17
AU670083B2 (en) 1996-07-04
JPH07506570A (ja) 1995-07-20
ITRM930286A0 (it) 1993-05-06
OA10109A (en) 1996-12-18
HU227338B1 (en) 2011-04-28
HU211638A9 (en) 1995-12-28
IL105468A (en) 1998-09-24
KR100253111B1 (en) 2000-07-01
AU4064093A (en) 1993-11-29
NZ252132A (en) 1996-09-25
FR2690847B1 (fr) 1995-06-09

Similar Documents

Publication Publication Date Title
ATE331726T1 (de) Adenine-derivate
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
NO20061737L (no) Aminosubstituerte erylamino B2 adrenergiske receptoragonister
ITRM920155A0 (it) Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil-1h-indol-5-metansolfonammide, e relativo procedimento di preparazione e trattamento con essa di mammiferi.
NO951613L (no) Ikke-peptidyl tachykinin reseptorantagonister
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
AR024138A1 (es) Inhibidores de la proliferacion celular
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
DE69328558D1 (de) Pharmazeutisches Präparat zur synergistischen Aktivierung natürlicher Killerzellen
NO944214D0 (no) Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
SE9702002D0 (sv) Novel compounds
NO995685D0 (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
NO950177D0 (no) Farmakologisk aktive erivater
DE59303446D1 (de) Neue bis-phenyl-hexene
ECSP972347A (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
ECSP972049A (es) Derivados de lactama
AR011169A1 (es) Compuestos derivados de quinoxalinadionas, su uso para la preparacion de medicamentos, compuestos intermediarios y procedimiento para preparar dichos medicamentos

Legal Events

Date Code Title Description
MK1K Patent expired